Toggle Menu
Stocknear
ctrl
K
/
Search
Popular
KO
Coca Cola Company
Stock
TSLA
Tesla Inc
Stock
AMD
Advanced Micro Devices
Stock
SPY
SPDR S&P 500 ETF Trust
ETF
NVDA
Nvidia
Stock
Login
Watchlist
Price Alert
Allogene Therapeutics Inc...
(ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.09
-0.02
(-1.80%)
At close:
May 22, 2025, 3:59 PM
1.09
-0.45%
After-hours:
May 22, 2025, 07:33 PM EDT
Overview
Financials
Statistics
Metrics
Forecast
Dark Pool
Options
Insider
Dividends
History
Profile
Overview
License
Allogene Therapeutics Revenue Breakdown
Period Ending
Dec 31, 2024
License Revenue
4.6M
License Revenue Growth
n/a
Operating Expense Breakdown
Period Ending
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Mar 31, 2021
Dec 31, 2020
Sep 30, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018
Dec 31, 2017
Selling, General, and Administrative Revenue
14.99M
15.52M
16.33M
16.09M
17.27M
17.22M
17.04M
18.52M
18.88M
21M
18.9M
19.51M
19.9M
19.96M
19M
18.78M
16.36M
17.13M
16.62M
15.86M
15.64M
15.21M
15.02M
14.19M
13.06M
14.54M
11.32M
12.53M
2.6M
2K
Selling, General, and Administrative Revenue Growth
-3.40%
-4.99%
+1.53%
-6.83%
+0.25%
+1.07%
-8.01%
-1.91%
-10.08%
+11.14%
-3.14%
-1.95%
-0.32%
+5.06%
+1.15%
+14.79%
-4.50%
+3.10%
+4.77%
+1.41%
+2.82%
+1.31%
+5.84%
+8.65%
-10.20%
+28.50%
-9.65%
+382.33%
+129750.00%
n/a
Research and Development Revenue
50.2M
44.97M
44.71M
50.35M
52.26M
54.66M
45.98M
62.04M
80.24M
75.42M
63.64M
57.17M
60.16M
53.98M
58.72M
52.29M
55.18M
52.23M
51.42M
47.3M
42.04M
49.36M
39.99M
31.77M
23.4M
18.5M
10.87M
122.49M
n/a
n/a
Research and Development Revenue Growth
+11.63%
+0.58%
-11.20%
-3.64%
-4.39%
+18.89%
-25.89%
-22.68%
+6.39%
+18.51%
+11.32%
-4.96%
+11.44%
-8.07%
+12.30%
-5.24%
+5.66%
+1.57%
+8.72%
+12.50%
-14.83%
+23.42%
+25.87%
+35.77%
+26.48%
+70.23%
-91.13%
n/a
n/a
n/a
Add to Watchlist
✕